Stocks Screener

Specify a stock or a cryptocurrency in the search bar to get a summary

Internet Computer ICP
Bitcoin Cash BCH
Litecoin LTC
Field stub for analysis

CARGO Therapeutics, Inc. Common Stock

CRGX
Current price
16 USD -1.21 USD (-7.03%)
Last closed 17 USD
Company
ISIN unknown
Sector Healthcare
Industry Biotechnology
Exchange NASDAQ
Capitalization 1 026 426 880 USD
Yield for 12 month +8.55 %
1Y
3Y
5Y
10Y
15Y
CRGX
21.11.2021 - 28.11.2021

CARGO Therapeutics, Inc., a clinical-stage biotechnology company, develops chimeric antigen receptor (CAR) T-cell therapies for cancer patients. The company's lead program is CRG-022, an autologous CD22 CAR T-cell product candidate designed to address resistance mechanisms by targeting CD22, an alternate tumor antigen that is expressed in B-cell malignancies. It also develops CRG-023, a tri-specific CAR T product candidate that targets tumor cells with three B-cell antigen targets. The company was formerly known as Syncopation Life Sciences, Inc. and changed its name to CARGO Therapeutics, Inc. in September 2022. CARGO Therapeutics, Inc. was incorporated in 2019 and is headquartered in San Mateo, California. Address: 1900 Alameda De Las Pulgas, San Mateo, CA, United States, 94403

Check your investment idea

Find the best to beat the market
TSLA TSLA Tesla Motors
AAPL AAPL Apple
MSFT MSFT Microsoft

Analytics

WallStreet Target Price

31.5 USD

P/E ratio

Dividend Yield

Current Year

Last Year

Current Quarter

Last Quarter

Current Year

-3 692 000 USD

Last Year

-1 444 000 USD

Current Quarter

-2 061 000 USD

Last Quarter

-1 854 000 USD

Key Figures CRGX

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
EBITDA -151 634 000 USD
Operating Margin TTM
PE Ratio
Return On Assets TTM -34.92 %
PEG Ratio
Return On Equity TTM -63.22 %
Wall Street Target Price 31.5 USD
Revenue TTM
Book Value 9.51 USD
Revenue Per Share TTM
Dividend Share
Quarterly Revenue Growth YOY
Dividend Yield
Gross Profit TTM
Earnings per share -17.64 USD
Diluted Eps TTM -17.64 USD
Most Recent Quarter II 2024
Quarterly Earnings Growth YOY
Profit Margin

Dividend Analytics CRGX

Dividend growth over 5 years

Continuous growth

Payout Ratio 5 years average

Dividend History CRGX

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Forward Annual Dividend Rate
Ex Dividend Date
Forward Annual Dividend Yield
Last Split Factor
Payout Ratio
Last Split Date
Dividend Date

Stock Valuation CRGX

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Trailing PE
Forward PE
Enterprise Value Revenue
Price Sales TTM
Enterprise Value EBITDA -12.1597
Price Book MRQ 2.3536

Financials CRGX

1 year
3 years
5 years
10 years
15 years
Results 2019 Dynamics
* The data for this period has not yet been published

Technical indicators CRGX

For 52 weeks

13.56 USD 33.92 USD
50 Day MA 20.54 USD
Shares Short Prior Month 5 074 185
200 Day MA 20.13 USD
Short Ratio 13.22
Shares Short 5 430 248
Short Percent 13.72 %